Use for treating obesity and diabetes

Abstract

Disclosed herein is the use of a composition, containing isoflavone- containing soybean extract, L-carnitine, caffeine and arginine as active ingredients, for the treatment of obesity and diabetes. The disclosed composition contains isoflavone -containing soybean extract, carnitine, caffeine and arginine in the form of a mixture, and thus shows not only the effect of promoting lipolysis and fat burning, but also anti-obesity and anti-diabetic effects by increasing the expressions of adiponectin and Glut4 genes to restore insulin sensitivity.

Description

technical field [0001] The present invention relates to the use of a composition for treating obesity and diabetes, which contains the following substances as active components: isoflavone-containing soybean extract, L-carnitine, caffeine and arginine. Background technique [0002] In the human body, there are about 2×10 10 A fatty acid that is used in mammals to store or release energy. The energy in these cells is stored and released according to a complex regulatory mechanism, and when the supply of energy is much greater than the demand, fatty acids are stored as neutral fats, and when energy is consumed, the neutral fats are decomposed into free fatty acids and glucose. Therefore, obesity is believed to arise when excess energy is stored due to an imbalance in the process of storing and releasing energy, and is attributed to an increase in the size and number of fatty acids. [0003] Obesity, which affects 30-40% of modern humans, is thought to be a causative factor ...

AI Technical Summary

Problems solved by technology

However, in patients with type 2 diabetes, obesity and diabetes resistance are closely related, so that when obesity becomes severe, insulin resistance becomes severe

[0005] Dyslipidemia in type 2 diabetes often improves with blood glucose regulation, but in some patients it does not

However, these drugs exhibit anti-obesity effects through the appetite mechanism of suppressing appetite and fat absorption, rather than promoting fat burning and breakdown, and thus, are insufficient to address insulin resistance

Thus, these drugs cannot completely solve diabetes and obesity, and in addition, serious adverse reactions of these drugs have been reported, so that their safety has not been established

Images